JP2018526403A5 - - Google Patents

Download PDF

Info

Publication number
JP2018526403A5
JP2018526403A5 JP2018512407A JP2018512407A JP2018526403A5 JP 2018526403 A5 JP2018526403 A5 JP 2018526403A5 JP 2018512407 A JP2018512407 A JP 2018512407A JP 2018512407 A JP2018512407 A JP 2018512407A JP 2018526403 A5 JP2018526403 A5 JP 2018526403A5
Authority
JP
Japan
Prior art keywords
formulation
antibody
intestinal wall
item
penetrating member
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2018512407A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018526403A (ja
Filing date
Publication date
Priority claimed from US15/150,379 external-priority patent/US11548940B2/en
Application filed filed Critical
Priority claimed from PCT/US2016/050832 external-priority patent/WO2017044665A1/en
Publication of JP2018526403A publication Critical patent/JP2018526403A/ja
Publication of JP2018526403A5 publication Critical patent/JP2018526403A5/ja
Priority to JP2021125408A priority Critical patent/JP2021169530A/ja
Withdrawn legal-status Critical Current

Links

JP2018512407A 2015-09-08 2016-09-08 嚥下可能な薬物送達デバイスを使用する腸管の管腔中への送達のためのｐｃｓｋ９抗体製剤 Withdrawn JP2018526403A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021125408A JP2021169530A (ja) 2015-09-08 2021-07-30 嚥下可能な薬物送達デバイスを使用する腸管の管腔中への送達のためのｐｃｓｋ９抗体製剤

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562215586P 2015-09-08 2015-09-08
US62/215,586 2015-09-08
US15/150,379 2016-05-09
US15/150,379 US11548940B2 (en) 2014-05-15 2016-05-09 Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
PCT/US2016/050832 WO2017044665A1 (en) 2015-09-08 2016-09-08 Pcsk9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021125408A Division JP2021169530A (ja) 2015-09-08 2021-07-30 嚥下可能な薬物送達デバイスを使用する腸管の管腔中への送達のためのｐｃｓｋ９抗体製剤

Publications (2)

Publication Number Publication Date
JP2018526403A JP2018526403A (ja) 2018-09-13
JP2018526403A5 true JP2018526403A5 (enExample) 2019-10-03

Family

ID=58240088

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018512407A Withdrawn JP2018526403A (ja) 2015-09-08 2016-09-08 嚥下可能な薬物送達デバイスを使用する腸管の管腔中への送達のためのｐｃｓｋ９抗体製剤
JP2021125408A Pending JP2021169530A (ja) 2015-09-08 2021-07-30 嚥下可能な薬物送達デバイスを使用する腸管の管腔中への送達のためのｐｃｓｋ９抗体製剤
JP2023084891A Withdrawn JP2023104992A (ja) 2015-09-08 2023-05-23 嚥下可能な薬物送達デバイスを使用する腸管の管腔中への送達のためのｐｃｓｋ９抗体製剤

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2021125408A Pending JP2021169530A (ja) 2015-09-08 2021-07-30 嚥下可能な薬物送達デバイスを使用する腸管の管腔中への送達のためのｐｃｓｋ９抗体製剤
JP2023084891A Withdrawn JP2023104992A (ja) 2015-09-08 2023-05-23 嚥下可能な薬物送達デバイスを使用する腸管の管腔中への送達のためのｐｃｓｋ９抗体製剤

Country Status (7)

Country Link
EP (1) EP3347050B1 (enExample)
JP (3) JP2018526403A (enExample)
CN (1) CN108401419A (enExample)
AU (2) AU2016320867B2 (enExample)
CA (1) CA2997958A1 (enExample)
DK (1) DK3347050T3 (enExample)
WO (1) WO2017044665A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10689460B2 (en) 2014-05-15 2020-06-23 Incube Labs, Llc PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
WO2015176031A2 (en) 2014-05-15 2015-11-19 Incube Labs, Llc Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins
US11541015B2 (en) 2017-05-17 2023-01-03 Massachusetts Institute Of Technology Self-righting systems, methods, and related components
US11207272B2 (en) 2017-05-17 2021-12-28 Massachusetts Institute Of Technology Tissue anchoring articles
US11202903B2 (en) 2018-05-17 2021-12-21 Massachusetts Institute Of Technology Systems for electrical stimulation
US12128133B2 (en) 2018-09-25 2024-10-29 Rani Therapeutics, Llc Ingestible device with expandable enclosure
US20200206132A1 (en) * 2018-12-31 2020-07-02 Incube Labs, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US11771829B2 (en) 2019-02-01 2023-10-03 Massachusetts Institute Of Technology Systems and methods for liquid injection
MX2021013310A (es) * 2019-05-03 2022-02-11 Rani Therapeutics Llc Preparaciones de factor de cogulación para la administración en el tejido del tracto intestinal usando un dispositivo de administración de medicamentos ingeribles.
US11541216B2 (en) 2019-11-21 2023-01-03 Massachusetts Institute Of Technology Methods for manufacturing tissue interfacing components

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8721620B2 (en) * 2009-12-24 2014-05-13 Rani Therapeutics, Llc Swallowable drug delivery device and methods of drug delivery
CN102905753B (zh) * 2009-12-24 2016-06-29 因卡伯实验室有限责任公司 可吞咽式药剂递送装置和药剂递送方法
US9149617B2 (en) 2010-12-23 2015-10-06 Rani Therapeutics, Llc Device, system and methods for the oral delivery of therapeutic compounds
ES2773115T3 (es) * 2011-06-29 2020-07-09 Rani Therapeutics Llc Preparados de agentes terapéuticos para la administración hacia el interior de una luz del tubo intestinal utilizando un dispositivo tragable para la administración de fármacos
CN103987422B (zh) * 2011-06-29 2017-02-15 拉尼医疗有限公司 用于治疗化合物的口服递送的装置、系统和方法
WO2013008185A1 (en) * 2011-07-14 2013-01-17 Pfizer Inc. Treatment with anti-pcsk9 antibodies
EA201691320A1 (ru) * 2014-02-14 2016-11-30 Ридженерон Фармасьютикалз, Инк. Способы лечения пациентов с гиперхолестеринемией, которая устойчива к терапии умеренными дозами статинов
EP3294273A4 (en) * 2015-05-08 2018-12-05 Incube Labs, LLC Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

Similar Documents

Publication Publication Date Title
AU2020256337B2 (en) Dosing regimens for echinocandin class compounds
JP5749255B2 (ja) Ｌ−オルニチンフェニル酢酸塩を用いる門脈圧亢進の治療及び肝機能の修復
JP4489356B2 (ja) 浸透促進剤
EP3316873B1 (en) Device for oral delivery of active agents
CN104379138B (zh) 阿坎酸制剂、其使用方法及包含阿坎酸制剂的组合
JP2005506367A5 (enExample)
JP2018519313A5 (enExample)
CA2654566A1 (en) Solid oral dosage form containing an enhancer
US20150024031A1 (en) Methods And Compositions For Reducing Pain, Inflammation, And/Or Immunological Reactions Associated With Parenterally Administering A Primary Therapeutic Agent
CN101277684A (zh) 至少一种活性成分改善释放的微粒及含有该微粒的口服药物剂型
Singh et al. Pulsatile drug delivery system: an approach of medication according to circadian rhythm
JP2022524446A5 (enExample)
US20110218246A1 (en) Methods of treating non-nociceptive pain states with gastric retentive gabapentin
JP2023120445A (ja) テルリプレシン組成物およびその使用方法
JP2005528430A5 (enExample)
WO2021145436A1 (ja) 目的とする既知の薬剤又はその等価物質の新たな適応症の予測方法、予測装置、及び予測プログラム
JP2018520995A5 (enExample)
MD3684344T2 (ro) Comprimate de deferipronă cu eliberare întârziată și metode de utilizare a acestora
CN117545509A (zh) 寡核苷酸的口服递送
WO2014176417A1 (en) Topical preparation for bypassing gi tract, delivery of therapeutics, and trans-epithelial drug delivery system
Pandey et al. Innovative approaches in HELICOBACTER pylori therapy: Clinical trials and advancements in Gastro-Retentive drug delivery systems
JP2019517490A (ja) がん療法のためのメトロノミック経口ゲムシタビン
JP4370054B2 (ja) 腸粘膜傷害の予防及び治療剤
RU2401112C2 (ru) Фармацевтическая композиция для лечения аутоиммунных заболеваний, связанных с повышенным образованием антител к нуклеиновым кислотам
JP6950958B2 (ja) 核酸を含む経腸投与用組成物